Prescriber's Corner

Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia

Michelle A. Borg, PharmD, and Amber Clemmons, PharmD, BCOP

University of Georgia College of Pharmacy and Augusta University Medical Center, Augusta, Georgia

Authors’ disclosures of potential conflicts of interest are found at the end of this article

Michelle A. Borg, PharmD, Augusta University Medical Center, 1120 15th Street, BI-2101, Augusta, GA 30912. E-mail: michelle.borg@nih.gov


J Adv Pract Oncol 2017;8:647–652 | https://doi.org/10.6004/jadpro.2017.8.6.8 | © 2017 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here